Interestingly, the overexpression of CB 1 Rs in adult mice undergoing experimental demyelination resulted in delayed onset and reduced severity of symptoms, whereas CB 1 R antagonism quickened symptom onset and increased the expression of inflammatory cytokines and NF-B proteins (Lou et al., 2016, 2018)
Importantly, unlike full-length HGH, AOD 9604 does not elevate IGF-1 levels or impact insulin sensitivity, making it a safer research candidate in metabolic studies
[CrossRef] [PubMed] [Google Scholar] The role of antioxidant enzymes in the ovaries
A 30-month, randomized, placebo-controlled trial of coenzyme Q 10 (600 mg/day), remacemide, or both in 347 patients with early Huntington's disease found that neither coenzyme Q 10 nor remacemide significantly altered the decline in total functional capacity, although coenzyme Q 10 supplementation (with or without remacemide) resulted in a nonsignificant trend toward a slower decline (73)